Novo Nordisk A/S (OTC Pink - Current Information:NONOF)

49.35
Delayed Data
As of Apr 17
 0.00 / 0.00%
Today’s Change
40.99
Today|||52-Week Range
52.54
+8.96%
Year-to-Date
Novo Nordisk's (NVO) Share Price Rises YTD on Strong Pipeline
9:51am / Zacks.com - Paid Partner Content
3 Top Diabetes Stocks to Watch in April
Apr 13 / MotleyFool.com - Paid Partner Content
Gilead Collaborates With Insitro to Develop NASH Therapies
Apr 17 / Zacks.com - Paid Partner Content
OmniStar Financial Group, Inc. Buys iShares Floating Rate Bond, British American Toba...
Apr 12 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal
Apr 17 / Zacks.com - Paid Partner Content
5 Companies That Will Raise Earnings
Apr 12 / GuruFocus News - Paid Partner Content
Gilead to Collaborate with Novo Nordisk for NASH Treatment
Apr 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close49.35
Today’s open48.61
Day’s range48.21 - 49.35
Volume71,397
Average volume (3 months)42,901
Market cap--
Data as of 3:13pm ET, 04/17/2019

Growth & Valuation

Earnings growth (last year)+8.07%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+4.51%
P/E ratio35.5
Price/Sales6.25
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$17.7B
Annual profit (last year)$6.1B
Net profit margin34.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts